InsidersTradesSigma
Follow the CMG제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, CMG제약 has logged 7 reports. Market capitalisation: €104.1bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: CMG제약. The full history is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,143 of 28,985 companies
25.2
score / 100
Value9
Quality41
FCF yld-51%
Earn yld-12%
EV/EBITDA·
ROE2.3%
Gross mgn58%
Net mgn-9.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 March 2026
About CMG제약
CMG제약 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.